HSP76_HUMAN - dbPTM
HSP76_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID HSP76_HUMAN
UniProt AC P17066
Protein Name Heat shock 70 kDa protein 6
Gene Name HSPA6
Organism Homo sapiens (Human).
Sequence Length 643
Subcellular Localization
Protein Description Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release. [PubMed: 26865365]
Protein Sequence MQAPRELAVGIDLGTTYSCVGVFQQGRVEILANDQGNRTTPSYVAFTDTERLVGDAAKSQAALNPHNTVFDAKRLIGRKFADTTVQSDMKHWPFRVVSEGGKPKVRVCYRGEDKTFYPEEISSMVLSKMKETAEAYLGQPVKHAVITVPAYFNDSQRQATKDAGAIAGLNVLRIINEPTAAAIAYGLDRRGAGERNVLIFDLGGGTFDVSVLSIDAGVFEVKATAGDTHLGGEDFDNRLVNHFMEEFRRKHGKDLSGNKRALRRLRTACERAKRTLSSSTQATLEIDSLFEGVDFYTSITRARFEELCSDLFRSTLEPVEKALRDAKLDKAQIHDVVLVGGSTRIPKVQKLLQDFFNGKELNKSINPDEAVAYGAAVQAAVLMGDKCEKVQDLLLLDVAPLSLGLETAGGVMTTLIQRNATIPTKQTQTFTTYSDNQPGVFIQVYEGERAMTKDNNLLGRFELSGIPPAPRGVPQIEVTFDIDANGILSVTATDRSTGKANKITITNDKGRLSKEEVERMVHEAEQYKAEDEAQRDRVAAKNSLEAHVFHVKGSLQEESLRDKIPEEDRRKMQDKCREVLAWLEHNQLAEKEEYEHQKRELEQICRPIFSRLYGGPGVPGGSSCGTQARQGDPSTGPIIEEVD
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
15PhosphorylationAVGIDLGTTYSCVGV
EECEECCCCEEEEEE
29.83-
17PhosphorylationGIDLGTTYSCVGVFQ
CEECCCCEEEEEEEE
10.42-
39PhosphorylationANDQGNRTTPSYVAF
ECCCCCCCCCCEEEE
47.2421945579
40PhosphorylationNDQGNRTTPSYVAFT
CCCCCCCCCCEEEEE
13.6521945579
42PhosphorylationQGNRTTPSYVAFTDT
CCCCCCCCEEEEECH
30.1021945579
43PhosphorylationGNRTTPSYVAFTDTE
CCCCCCCEEEEECHH
9.3021945579
47PhosphorylationTPSYVAFTDTERLVG
CCCEEEEECHHHHHH
32.0721945579
49PhosphorylationSYVAFTDTERLVGDA
CEEEEECHHHHHHHH
21.6821945579
51MethylationVAFTDTERLVGDAAK
EEEECHHHHHHHHHH
36.44-
58UbiquitinationRLVGDAAKSQAALNP
HHHHHHHHHCHHHCC
44.83-
59PhosphorylationLVGDAAKSQAALNPH
HHHHHHHHCHHHCCC
21.9624719451
73UbiquitinationHNTVFDAKRLIGRKF
CCCHHHHHHHHCCCC
49.97-
79UbiquitinationAKRLIGRKFADTTVQ
HHHHHCCCCCCCCCC
39.42-
90UbiquitinationTTVQSDMKHWPFRVV
CCCCCCCCCCCEEEE
47.73-
102UbiquitinationRVVSEGGKPKVRVCY
EEEEECCCCCEEEEE
53.15-
102AcetylationRVVSEGGKPKVRVCY
EEEEECCCCCEEEEE
53.15-
104UbiquitinationVSEGGKPKVRVCYRG
EEECCCCCEEEEECC
46.27-
114UbiquitinationVCYRGEDKTFYPEEI
EEECCCCCCCCHHHH
35.91-
115PhosphorylationCYRGEDKTFYPEEIS
EECCCCCCCCHHHHH
40.5020860994
117PhosphorylationRGEDKTFYPEEISSM
CCCCCCCCHHHHHHH
18.2429438985
123PhosphorylationFYPEEISSMVLSKMK
CCHHHHHHHHHHHHH
20.69-
127PhosphorylationEISSMVLSKMKETAE
HHHHHHHHHHHHHHH
21.2029438985
128UbiquitinationISSMVLSKMKETAEA
HHHHHHHHHHHHHHH
50.24-
130UbiquitinationSMVLSKMKETAEAYL
HHHHHHHHHHHHHHC
56.50-
136Nitrated tyrosineMKETAEAYLGQPVKH
HHHHHHHHCCCCCEE
11.67-
142UbiquitinationAYLGQPVKHAVITVP
HHCCCCCEEEEEEEE
32.31-
142MethylationAYLGQPVKHAVITVP
HHCCCCCEEEEEEEE
32.3123644510
151PhosphorylationAVITVPAYFNDSQRQ
EEEEEECCCCHHHCH
9.24-
155PhosphorylationVPAYFNDSQRQATKD
EECCCCHHHCHHHCC
28.5017525332
161UbiquitinationDSQRQATKDAGAIAG
HHHCHHHCCCCHHCC
48.90-
179PhosphorylationLRIINEPTAAAIAYG
HHHCCCHHHHHHHHC
23.8128152594
185PhosphorylationPTAAAIAYGLDRRGA
HHHHHHHHCCCCCCC
16.4728152594
224PhosphorylationGVFEVKATAGDTHLG
CEEEEEECCCCCCCC
26.0029396449
259UbiquitinationGKDLSGNKRALRRLR
CCCCCCCHHHHHHHH
42.44-
267PhosphorylationRALRRLRTACERAKR
HHHHHHHHHHHHHHH
40.0127273156
275PhosphorylationACERAKRTLSSSTQA
HHHHHHHHHCCCCCE
30.22-
278PhosphorylationRAKRTLSSSTQATLE
HHHHHHCCCCCEEHH
40.28-
298PhosphorylationEGVDFYTSITRARFE
CCCCCCHHHHHHHHH
15.5820860994
300PhosphorylationVDFYTSITRARFEEL
CCCCHHHHHHHHHHH
20.3120860994
309PhosphorylationARFEELCSDLFRSTL
HHHHHHHHHHHHHCC
50.3921712546
314PhosphorylationLCSDLFRSTLEPVEK
HHHHHHHHCCHHHHH
29.97-
315PhosphorylationCSDLFRSTLEPVEKA
HHHHHHHCCHHHHHH
30.7721712546
321UbiquitinationSTLEPVEKALRDAKL
HCCHHHHHHHHHCCC
53.6121890473
321AcetylationSTLEPVEKALRDAKL
HCCHHHHHHHHHCCC
53.6122640907
327UbiquitinationEKALRDAKLDKAQIH
HHHHHHCCCCHHHCC
62.6021890473
330UbiquitinationLRDAKLDKAQIHDVV
HHHCCCCHHHCCEEE
53.26-
330MethylationLRDAKLDKAQIHDVV
HHHCCCCHHHCCEEE
53.26-
330AcetylationLRDAKLDKAQIHDVV
HHHCCCCHHHCCEEE
53.26-
347UbiquitinationGGSTRIPKVQKLLQD
CCCCCCHHHHHHHHH
55.73-
350UbiquitinationTRIPKVQKLLQDFFN
CCCHHHHHHHHHHHC
54.9021890473
350AcetylationTRIPKVQKLLQDFFN
CCCHHHHHHHHHHHC
54.9025953088
359UbiquitinationLQDFFNGKELNKSIN
HHHHHCCCCCCCCCC
61.2021890473
359AcetylationLQDFFNGKELNKSIN
HHHHHCCCCCCCCCC
61.2024513421
359SumoylationLQDFFNGKELNKSIN
HHHHHCCCCCCCCCC
61.20-
363UbiquitinationFNGKELNKSINPDEA
HCCCCCCCCCCHHHH
66.39-
363SumoylationFNGKELNKSINPDEA
HCCCCCCCCCCHHHH
66.39-
364PhosphorylationNGKELNKSINPDEAV
CCCCCCCCCCHHHHH
26.9025159151
373PhosphorylationNPDEAVAYGAAVQAA
CHHHHHHHHHHHHHH
10.7418669648
386UbiquitinationAAVLMGDKCEKVQDL
HHHHCCCCCCHHHHE
38.27-
402PhosphorylationLLDVAPLSLGLETAG
EEECCCCCCCCCCCC
21.23-
407PhosphorylationPLSLGLETAGGVMTT
CCCCCCCCCCHHHHH
35.33-
414PhosphorylationTAGGVMTTLIQRNAT
CCCHHHHHHHHCCCC
12.0821601212
424PhosphorylationQRNATIPTKQTQTFT
HCCCCCCCCCEEEEE
31.7521601212
429PhosphorylationIPTKQTQTFTTYSDN
CCCCCEEEEEEECCC
26.74-
433PhosphorylationQTQTFTTYSDNQPGV
CEEEEEEECCCCCEE
15.80-
453UbiquitinationEGERAMTKDNNLLGR
ECCCCCCCCCCEECC
45.4321890473
460MethylationKDNNLLGRFELSGIP
CCCCEECCEEECCCC
23.10-
471MethylationSGIPPAPRGVPQIEV
CCCCCCCCCCCEEEE
61.9318600857
479PhosphorylationGVPQIEVTFDIDANG
CCCEEEEEEEECCCC
11.6415302935
495MethylationLSVTATDRSTGKANK
EEEEEEECCCCCCCE
31.59115384363
497PhosphorylationVTATDRSTGKANKIT
EEEEECCCCCCCEEE
43.53-
499UbiquitinationATDRSTGKANKITIT
EEECCCCCCCEEEEE
49.20-
502UbiquitinationRSTGKANKITITNDK
CCCCCCCEEEEECCC
46.1921890473
502AcetylationRSTGKANKITITNDK
CCCCCCCEEEEECCC
46.1922640903
504PhosphorylationTGKANKITITNDKGR
CCCCCEEEEECCCCC
24.2925159151
509SumoylationKITITNDKGRLSKEE
EEEEECCCCCCCHHH
48.26-
509UbiquitinationKITITNDKGRLSKEE
EEEEECCCCCCCHHH
48.2621890473
509SumoylationKITITNDKGRLSKEE
EEEEECCCCCCCHHH
48.26-
509AcetylationKITITNDKGRLSKEE
EEEEECCCCCCCHHH
48.2683037561
513PhosphorylationTNDKGRLSKEEVERM
ECCCCCCCHHHHHHH
36.3426091039
514UbiquitinationNDKGRLSKEEVERMV
CCCCCCCHHHHHHHH
63.59-
528UbiquitinationVHEAEQYKAEDEAQR
HHHHHHHHHHCHHHH
45.02-
541UbiquitinationQRDRVAAKNSLEAHV
HHHHHHHHHHHHEEE
37.01-
552UbiquitinationEAHVFHVKGSLQEES
HEEEEEECCCCCHHH
33.92-
563"N6,N6,N6-trimethyllysine"QEESLRDKIPEEDRR
CHHHHHHHCCHHHHH
54.44-
563UbiquitinationQEESLRDKIPEEDRR
CHHHHHHHCCHHHHH
54.44-
563MethylationQEESLRDKIPEEDRR
CHHHHHHHCCHHHHH
54.4423921388
591UbiquitinationEHNQLAEKEEYEHQK
HHHHHHCHHHHHHHH
50.68-
598UbiquitinationKEEYEHQKRELEQIC
HHHHHHHHHHHHHHH
50.15-
626PhosphorylationPGGSSCGTQARQGDP
CCCCCCCCCCCCCCC
24.31-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of HSP76_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of HSP76_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of HSP76_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SCFD1_HUMANSCFD1physical
22939629
HSP7C_HUMANHSPA8physical
22863883
DNJA1_HUMANDNAJA1physical
21231916
DNJA2_HUMANDNAJA2physical
21231916
DNJA4_HUMANDNAJA4physical
21231916
DNJB1_HUMANDNAJB1physical
21231916
DNJB4_HUMANDNAJB4physical
21231916
DNJB5_HUMANDNAJB5physical
21231916
DNJB6_HUMANDNAJB6physical
21231916
DNJB7_HUMANDNAJB7physical
21231916
DNJB8_HUMANDNAJB8physical
21231916

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of HSP76_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-321 AND LYS-502, AND MASSSPECTROMETRY.

TOP